Skip to main content
Svas Biosana logo

Svas Biosana — Investor Relations & Filings

Ticker · SVS ISIN · IT0005469264 LEI · 81560055A88E1D16D537 XMIL Manufacturing
Open in API
Filings indexed 284 across all filing types
Latest filing 2024-08-02 Earnings Release
Country IT Italy
Listing XMIL SVS

About Svas Biosana

https://svas.it/en/

Svas Biosana is a company that specializes in the planning, manufacturing, and distribution of medical devices and pharmaceutical products. The company's portfolio includes a range of disposable hospital supplies, such as incontinence aids and traditional dressings. Serving both public and private health institutions, Svas Biosana develops, produces, and distributes its own branded products as well as those from third-party manufacturers.

Recent filings

Filing Released Lang Actions
Ricavi consolidati al 30.06.2024
Earnings Release Classification · 98% confidence The document is a press release (COMUNICATO STAMPA) from Svas Biosana S.p.A. dated August 2, 2024. The subject (Oggetto) is 'Ricavi consolidati al 30.06.2024' (Consolidated revenues as of June 30, 2024). It details the company's consolidated revenues for the first six months of the year, presenting key figures and comparisons. This content aligns perfectly with an Earnings Release (ER), which is the initial announcement of periodical financial results, typically containing key highlights before a more comprehensive report (like an IR or 10-K) is issued. Although it contains a table of results, its format and explicit mention of examining revenues for a specific period (H1 2024) classify it as an ER rather than a comprehensive Interim Report (IR) or a mere announcement of a report (RPA). H1 2024
2024-08-02 Italian
Acquisto azioni proprie
Transaction in Own Shares Classification · 100% confidence The document is titled "INFORMATIVA SETTIMANALE ACQUISTO AZIONI PROPRIE" (Weekly Information on Own Share Purchase) and details the number of shares purchased by Svas Biosana S.p.A. during a specific weekly period (July 29, 2024, to August 2, 2024), including the average price and total consideration. This activity—the company buying back its own shares—directly corresponds to the definition of 'Transaction in Own Shares'. The code for this is POS. The document is a formal communication (Regulated Information No. 20240-41-2024) detailing the transaction, not just an announcement that a report is forthcoming, thus ruling out RPA/RNS based on the 'Menu vs Meal' rule, as this is the actual transaction report.
2024-08-02 Italian
Chiusura 3° periodo esercizio Warrant
Share Issue/Capital Change Classification · 99% confidence The document is an official communication from SVAS BIOSANA S.p.A. titled "CHIUSURA DEL TERZO ED ULTIMO PERIODO DI ESERCIZIO DEI WARRANT SVAS BIOSANA 2021-2024" (Closure of the Third and Final Exercise Period of the SVAS BIOSANA 2021-2024 Warrants). It explicitly states the conclusion of the warrant exercise period and the resulting non-issuance of new shares. This relates directly to the company's capital structure and financing instruments. While it is a regulatory announcement (Informazione Regolamentata), the specific subject matter—the expiration/closure of a financing instrument (warrants)—fits best under the Capital/Financing Update category (CAP), as it finalizes a capital event. It is not a general earnings release (ER), a full annual report (10-K), or a simple dividend notice (DIV). Since it details the outcome of a capital event, CAP is the most precise fit over the general RNS.
2024-07-31 Italian
Acquisto Azioni Proprie
Transaction in Own Shares Classification · 100% confidence The document is titled "INFORMATIVA SETTIMANALE ACQUISTO AZIONI PROPRIE" (Weekly Information on Own Share Purchase) and details the number of shares purchased by Svas Biosana S.p.A. between July 22, 2024, and July 26, 2024, including daily breakdowns and the total number of treasury shares held. This activity—the company buying back its own shares—directly corresponds to the definition of 'Transaction in Own Shares'. The filing code for this is POS.
2024-07-26 Italian
Acquisto azioni proprie
Transaction in Own Shares Classification · 98% confidence The document is titled "INFORMATIVA SETTIMANALE ACQUISTO AZIONI PROPRIE" (Weekly Information on Own Share Purchase) and the subject ('Oggetto') is "Acquisto azioni proprie" (Purchase of own shares). It explicitly states that no purchase operations were executed in the specified weekly period (July 15 to July 19, 2024) under the share buyback program authorized by the Shareholders' Meeting. This type of filing, reporting on the status of a share repurchase program, directly corresponds to the definition of 'Transaction in Own Shares' (POS). The document is a formal regulatory disclosure (Informazione Regolamentata) detailing the status of treasury stock transactions.
2024-07-19 Italian
Acquisto azioni proprie
Transaction in Own Shares Classification · 100% confidence The document is titled "INFORMATIVA SETTIMANALE ACQUISTO AZIONI PROPRIE" (Weekly Information on Own Share Purchase) and details the number of shares purchased by Svas Biosana S.p.A. between July 8, 2024, and July 12, 2024. This activity—the company buying back its own shares—directly corresponds to the definition of 'Transaction in Own Shares'. The filing code for this is POS. Although it is a weekly report, the core subject is the share repurchase program, making POS more specific than a general Regulatory Filing (RNS) or Report Publication Announcement (RPA).
2024-07-12 Italian

Browse filings by year

6 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.